Skip to main content

Seagen loses arbitration decision against Japanese drugmaker Daiichi Sankyo

The decision comes after Seagen won a $41.8 million patent infringement case against Daiichi Sankyo in April.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.